Lymphoid Malignancies
📧 Sign up to get email alerts when something new happens for Lymphoid Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AVM0703 for lymphoid malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy [Phase 1]
Phase 1 clinical trial sponsored by the University of Alabama at Birmingham evaluating UAB 2419-CD34 selection using the CliniMACS Prodigy s…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies [Phase 1]
This ClinicalTrials.gov listing describes a Phase 1 study of BL-M08D1 in patients with relapsed or refractory lymphoid malignancies, and the…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies [EARLY_Phase 1]
UTAA07 Injection is being studied in an early-phase 1 clinical trial for hematologic and lymphoid malignancies and is currently recruiting.
-
CLINICAL_TRIALS research · 2017-11-21Clinical Trial Update: Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer [Phase 1]
This Phase 1 study assesses the oral bioavailability of a new ABT-263 (navitoclax) formulation in cancer patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.